Kdventures gets two USPTO notices of allowance for Umecrine Cognition patent applications
Kdventures AB said its Umecrine Cognition patent applications received two USPTO notices of allowance.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Umecrine Cognition gets two US Notices of Allowance on GAMSA compounds
KDventures AB says its portfolio company Umecrine Cognition received two Notices of Allowance from the USPTO for patent applications covering two second-generation GAMSA compound candidates.